As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.


Figure S1: Neutralization of DENV-2 strain P23085 in vivo and in vitro with a specific monoclonal antibody prevents lethality associated to severe disease in infected WT mice.

Figure S2. Molecular characterization of DENV-2-adapted strain P23085.

Figure S3. Th17 genes expression in infected WT mice and clinical parameters in infected IL-17RA-/- mice.

Figure S4. Hematology and liver histopathology in anti-IL-17A-antibody-treated WT mice infected with DENV-2.

Figure S5. Gating strategy used for flow cytometry (FACS) analysis after DENV-2 infection.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.